Delivery Order SPE2DR25D6028-SPE2DR26FASKG
- Not listed
- AmerisourceBergen Drug Corp was awarded a $2,251.18 delivery order by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, for the supply of Levophed (norepinephrine) 4ml vials in a quantity of 10 units. The contract is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as the contractor's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,319.13 to AmerisourceBergen Drug Corp for the supply of Levophed 4 mg/4 mL vials on December 15, 2025, with an ultimate completion date of December 16, 2025. This non-competed delivery order utilizes firm fixed pricing and is fulfilled from the place of performance located in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $4,935.52 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Levophed (norepinephrine) intravenous solution in 4ml vials, quantity 10 units. This is a firm fixed price, non-set-aside order with performance in Conshohocken, Pennsylvania, scheduled for completion by December 30, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Levophed (norepinephrine) in 4 milliliter vials, quantity 10, with a ceiling value of $3,567.04 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for Levophed SDV 4ML in quantities of 10, with a ceiling value of $3,076.85. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,802.12 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Levophed (norepinephrine) in 4ml vials, a critical vasopressor medication used in emergency and intensive care settings. This firm fixed-price delivery order, with a completion date of September 29, 2025, was competitively awarded without set-aside designation and will be performed at the contractor's corporate headquarters in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Levophed SDV 4ML in a quantity of 10 units, with a ceiling value of $6,189.90. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on December 22, 2025, with an ultimate completion date of January 21, 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Levophed (norepinephrine) is a critical vasopressor...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $1,051.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Levophed (norepinephrine) intravenous solution, 4mL vials in a 10-pack unit. The delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive, non-set-aside award. Levophed is a critical vasopressor medication used in emergency and intensive care settings to treat hypotension and maintain...
- The Defense Logistics Agency awarded a delivery order valued at $1,783.99 to AmerisourceBergen Drug Corp for the supply of Norepinephrine 4 mg/4 mL vials on December 12, 2025, with a completion deadline of December 15, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,756.64 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Norepinephrine 4 mg/4 mL vials (4 mL quantity). This firm fixed-price contract represents a non-competitive set-aside and will be performed at the vendor's location in Conshohocken, Pennsylvania, with a completion deadline of December 4, 2025. The contract falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASKGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $4,836.36, for the supply of Levophed (norepinephrine) in 4ml vials, 10-count packages. This firm fixed-price delivery order, with an ultimate completion date of January 5, 2026, was competitively awarded without set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations supporting federal medical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's contract portfolio demonstrates its established capability as a critical vendor for federal medical supply needs, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 12/4/25 |